Genmab — Juni 2018
-
Det kan ikke være nemt at tiltrække eller fastholde talent, når aktieaflønningen halter så voldsomt
-
yes, i am sure you are correct. - but perhaps not this afternoon,
as genmabbers are cellebrating their new home https://twitter.com/search?f=tweets&vertical=default&q=genmab OR daratumumab OR darzalex OR ofatumumab&src=savs https://twitter.com/adviesbureauDWA/status/1012345978802835456 -
ro på - det bliver ikke hyret kernekompetencer
-
-
God morgen.
-
God morgen
-
God morgen
Min 6 uger gamle datter har holdt mig vågen det meste af natten - da jeg endelig fik lov at sove lidt drømte jeg at jeg blev tilbudt 1500 GEN aktier for hende 
-
Jeg takkede naturligvis også nej
Var det konen, så er det en helt anden snak
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind